Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liraglutide in Autoimmune Diabetes Mellitus
NCT03011008Phase 4Unknown
- Sponsor
- The Second Xiangya Hospital
- Start
- Jan 2017
- Primary completion
- Dec 2020
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 4 trial of liraglutide in type 1 diabetes mellitus (T1D), latent autoimmune diabetes in adults (LADA), sponsored by The Second Xiangya Hospital. Status: unknown.
02
Drugs
03
Conditions
type 1 diabetes mellitus (T1D)latent autoimmune diabetes in adults (LADA)
Beyond the preview
Go deeper on NCT03011008.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03011008.